NO951608D0 - Anvendelse av BHAP-forbindelser i kombinasjon med andre ikke-nukleoside reverstranskriptaseinhibitorer for behandling av HIV-infeksjon - Google Patents

Anvendelse av BHAP-forbindelser i kombinasjon med andre ikke-nukleoside reverstranskriptaseinhibitorer for behandling av HIV-infeksjon

Info

Publication number
NO951608D0
NO951608D0 NO951608A NO951608A NO951608D0 NO 951608 D0 NO951608 D0 NO 951608D0 NO 951608 A NO951608 A NO 951608A NO 951608 A NO951608 A NO 951608A NO 951608 D0 NO951608 D0 NO 951608D0
Authority
NO
Norway
Prior art keywords
bhap
compounds
treatment
combination
reverse transcriptase
Prior art date
Application number
NO951608A
Other languages
English (en)
Other versions
NO951608L (no
Inventor
William Gary Tarpley
Thomas Jerome Dueweke
Donald Herman M D Batts
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO951608D0 publication Critical patent/NO951608D0/no
Publication of NO951608L publication Critical patent/NO951608L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO951608A 1992-10-28 1995-04-27 Anvendelse av BHAP-forbindelser i kombinasjon med andre ikke-nukleoside reverstranskriptaseinhibitorer for behandling av HIV-infeksjon NO951608L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96763992A 1992-10-28 1992-10-28
US1711993A 1993-02-12 1993-02-12
PCT/US1993/008354 WO1994009781A1 (en) 1992-10-28 1993-09-10 Use of bhap compounds in combination with other non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infection

Publications (2)

Publication Number Publication Date
NO951608D0 true NO951608D0 (no) 1995-04-27
NO951608L NO951608L (no) 1995-06-28

Family

ID=26689480

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951608A NO951608L (no) 1992-10-28 1995-04-27 Anvendelse av BHAP-forbindelser i kombinasjon med andre ikke-nukleoside reverstranskriptaseinhibitorer for behandling av HIV-infeksjon

Country Status (12)

Country Link
EP (1) EP0666744A1 (no)
JP (1) JPH08502745A (no)
KR (1) KR950703958A (no)
AU (1) AU4848293A (no)
CA (1) CA2145545A1 (no)
CZ (1) CZ69695A3 (no)
FI (1) FI952018A (no)
HU (1) HUT72050A (no)
MX (1) MX9306031A (no)
NO (1) NO951608L (no)
PL (1) PL308551A1 (no)
WO (1) WO1994009781A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW406075B (en) * 1994-12-13 2000-09-21 Upjohn Co Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
MXPA03008143A (es) 2001-03-09 2005-08-16 Johnson & Johnson Compuestos heterociclicos.
WO2004022060A2 (en) 2002-09-06 2004-03-18 Janssen Pharmaceutica, N.V. (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders
TW201201813A (en) 2010-03-31 2012-01-16 Arqule Inc Substituted benzo-pyrido-triazolo-diazepine compounds
TW201307347A (zh) 2010-11-01 2013-02-16 Arqule Inc 經取代苯並－咪唑並－吡啶並－二氮呯化合物

Also Published As

Publication number Publication date
MX9306031A (es) 1994-04-29
CA2145545A1 (en) 1994-05-11
JPH08502745A (ja) 1996-03-26
FI952018A0 (fi) 1995-04-27
FI952018A (fi) 1995-04-27
HUT72050A (en) 1996-03-28
WO1994009781A1 (en) 1994-05-11
AU4848293A (en) 1994-05-24
EP0666744A1 (en) 1995-08-16
PL308551A1 (en) 1995-08-21
CZ69695A3 (en) 1995-12-13
HU9501218D0 (en) 1995-06-28
KR950703958A (ko) 1995-11-17
NO951608L (no) 1995-06-28

Similar Documents

Publication Publication Date Title
NO306459B1 (no) Amidinderivater med nitrogenoksydsyntetaseaktiviteter, farmasöytisk preparat og anvendelse av amidinderivatene
FI931097A0 (fi) Laekemedel, deras framstaellning och anvaendning vid bekaempning av smaertor och/eller inflammationen hos maenniskor och djur
FI941222A0 (fi) Ei-peptidyyli-tyyppisiä integriini-inhibiittoreita, jotka ovat spesifisiä GPIIbIIIa-reseptorin suhteen
DK0509019T3 (da) Behandling af humane retrovirale infektioner med 2',3'-dideoxyinosin
PT824524E (pt) Compostos de pirimidina-tioalquilo e alquileter substituidos em alfa como inibidores da transcriptase reversa viral
NO953370D0 (no) Anvendelse av riluzol ved behandling av neuro-AIDS
FI953954A (fi) HIV:n käänteistranskriptaasin inhibiittoreita
IL99843A0 (en) Synergistic combination of hiv reverse transcriptase inhibitors
DK261490D0 (da) New pharmaceutical compound
ES2123156T3 (es) Compuestos y procedimientos de inhibicion de hiv y virus semejantes.
OA09917A (en) Compounds for use in treating HIV infection
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
NO951608D0 (no) Anvendelse av BHAP-forbindelser i kombinasjon med andre ikke-nukleoside reverstranskriptaseinhibitorer for behandling av HIV-infeksjon
FI945199A0 (fi) HIV-käänteiskopioijaentsyymin uudet kinatsoliini-inhibiittorit
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
FI862251A0 (fi) Spiro-imidazolidiner som inhibitorer foer aldosreduktas.
YU6396A (sh) Kombinacija inhibitora hiv proteaze sa drugim jedinjenjima za terapiju hiv infekcija
DK694188A (da) Anvendelse af ace-inhibitor til laegemiddelfremstilling, evt. i kombination med et calciumkanalblokeringsmiddel
NO20002481L (no) Kombinasjonsterapi for behandling av AIDS
FI945446A (fi) Kotiinin käyttö tupakan vieroitusoireyhtymän lievittämiseksi
NO960545D0 (no) Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin
MX9700036A (es) Combinacion de compuestos, uso en la preparacion de composiciones para tratar infeccion por el vir s de inmunodeficiencia humana, y composiciones obtenidas.
DK0774969T3 (da) HIV-proteaseinhibitor kombination
SU1095491A1 (ru) Средство дл лечени кардиалгий и легких форм ишемической болезни сердца "мебикар
ATE178800T1 (de) Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung